VALORAN

This brand name is authorized in Cyprus, Estonia, Hong Kong SAR China, Malta, Spain.

Active ingredients

The drug VALORAN contains one active pharmaceutical ingredient (API):

1	Cefotaxime UNII N2GI8B1GK7 - CEFOTAXIME
	Cefotaxime exerts its action by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thereby inhibiting cell wall synthesis.
	Read more about Cefotaxime

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VALORAN Powder for solution for injection or infusion	MPI, EU: SmPC	Υπουργείο Υγείας (CY)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD01	Cefotaxime	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1120914, 1120925, 1120936, 1120958, 1120969, 1120970
ES	Centro de información online de medicamentos de la AEMPS	83550, 83551
HK	Department of Health Drug Office	35053, 35054, 35056
MT	Medicines Authority	MA032/12901, MA032/12902